Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Oct 25, 2024 |
EVP & CFO
Trans History: 84
|
EVP & CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 752 | -- | 92,793 |
Oct 25, 2024 |
Director
Trans History: 89
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 230 | -- | 27,723 |
Oct 25, 2024 |
Director
Trans History: 114
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 273 | -- | 27,850 |
Oct 25, 2024 |
Director
Trans History: 632
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 156 | -- | 122,515 |
Oct 25, 2024 |
Principal Accounting Officer
Trans History: 32
|
Principal Accounting Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 56 | -- | 6,363 |
Oct 25, 2024 |
EVP & General Counsel
Trans History: 247
|
EVP & General Counsel | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 508 | -- | 90,448 |
Oct 25, 2024 |
Chief of Staff
Trans History: 141
|
Chief of Staff | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 644 | -- | 97,160 |
Oct 25, 2024 |
Director
Trans History: 28
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 86 | -- | 8,699 |
Sep 30, 2024 |
EVP Chief Risk Officer
Trans History: 54
|
EVP Chief Risk Officer | Form 4 | Open market or private purchase of non-derivative or derivative security | 54 | $20.22 | 2,636 |
Sep 30, 2024 |
Director, President & CEO
Trans History: 659
|
Director, President & CEO | Form 4 | Open market or private purchase of non-derivative or derivative security | 86 | $20.22 | 13,622 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.